nPOD. Publications

2013 Publications (25)

In Print

Toniolo A , Salvatoni A, Federico G, Diaz-Horta O, Maccari G, Baj A (2013). Enteroviruses in blood. In: “Diabetes and Viruses”. K Taylor, H Hyoty, A Toniolo, A Zuckerman (Eds.), Springer, New York, 2013; pp. 143-156.

Fiaschi-Taesch NM, Kleinberger JW, Salim FG, Troxell R, Wills R, Tanwir M, Casinelli G, Cox AE, Takane KK, Scott DK, Stewart AF. (2013) Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas. Diabetes. 2013 Jul;62(7):2450-9. doi: 10.2337/db12-0777. Epub 2013 Mar 14.

Dahan R, Gebe JA, Preisinger A, James EA, Tendler M, Nepom GT, Reiter Y. (2013) Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope. J Autoimmun. 2013 Dec;47:83-93. doi: 10.1016/j.jaut.2013.08.009. Epub 2013 Oct 3.

Pietropaolo M. (2013) Persistent C-peptide: what does it mean? Curr Opin Endocrinol Diabetes Obes. Aug;20(4):279-84. doi: 10.1097/MED.0b013e3283628610.

Richardson, S.J., Leete, P., Bone, A.J., Foulis, A.K., Morgan, N.G. (2013). Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia, 56(1): 185-193.

Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine AB, Hyöty H, Morgan NG, Korsgren O, Frisk G. (2013). Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: Assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol. 2013 Nov 19. doi: 10.1002/jmv.23835. [Epub ahead of print]

Puri S, Akiyama H, Hebrok M. (2013) VHL-mediated disruption of Sox9 activity compromises β-cell identity and results in diabetes mellitus. Genes Dev. 27(23):2563-75. doi: 10.1101/gad.227785.113.

Imai Y, Dobrian AD, Weaver JR, Butcher MJ, Cole BK, Galkina EV, Morris MA, Taylor-Fishwick DA, Nadler JL. (2013) Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab. 2013 Sep;15 Suppl 3:117-29. doi: 10.1111/dom.12161.

Kavishwar A, Moore A. (2013) Sphingomyelin patches on pancreatic beta-cells are indicative of insulin secretory capacity. J Histochem Cytochem. 61(12):910-9. doi: 10.1369/0022155413502792. Epub 2013 Aug 6.

Mallone R, Roep BO. (2013) Biomarkers for immune intervention trials in type 1 diabetes. Clin Immunol. 149(3):286-96. doi: 10.1016/j.clim.2013.02.009. Epub 2013 Feb 27. Review.

Yip L, Taylor C, Whiting CC, Fathman CG. (2013) Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes. Diabetes., 62(12):4208-19. doi: 10.2337/db13-0614.

Oram RA, Jones AG, Besser RE, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ. (2013) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia. [Epub ahead of print]

Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. (2013) Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.

Rowe P, Wasserfall C, Croker B, Campbell-Thompson M, Pugliese A, Atkinson M, Schatz D. (2013) Increased complement activation in human type 1 diabetes pancreata. Diabetes Care. doi: 10.2337/dc13-0203. Epub 2013 Sep 16.

Harja E, Lord J, Skyler JS. (2013) An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology. Diabetes Technol Ther. 15(8):609-18. doi: 10.1089/dia.2013.0177. Epub 2013 Aug 8.

Gardner JM, Metzger TC, McMahon EJ, Au-Yeung BB, Krawisz AK, Lu W, Price JD, Johannes KP, Satpathy AT, Murphy KM, Tarbell KV, Weiss A, Anderson MS. (2013) Extrathymic Aire-Expressing Cells are a Distinct Bone Marrow-Derived Population that Induce Functional Inactivation of CD4+ T Cells Immunity. 19;39(3):560-72. doi: 10.1016/j.immuni.2013.08.005. Epub 2013 Aug 29.

Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas CJ, Discepolo V, Jabri B, Waldmann TA. (2013) Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc Natl Acad Sci U S A.110(33):13534-9. doi: 10.1073/pnas.1312911110. Epub 2013 Jul 31.

Spagnuolo I, Patti A, Sebastiani G, Nigi L, Dotta F. (2013). The case for virus-induced type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. Aug;20(4):292-8. doi: 10.1097/MED.0b013e328362a7d7.

Nelson EK, Piehler B, Rauch A, Ramsay S, Holman D, Asare S, Asare A, Igra M. (2013). Ancillary study management systems: a review of needs BMC Med Inform Decis Mak., 13(5). doi: 10.1186/1472-6947-13-5.

Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, Rowe PA, Tracy S, In’t Veld PA. (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 56(11):2541-3. doi: 10.1007/s00125-013-3043-5. Epub 2013 Sep 5.

Hodik M, Lukinius A, Korsgren O, Frisk G. (2013) Tropism Analysis of Two Coxsackie B5 Strains Reveals Virus Growth in Human Primary Pancreatic Islets but not in Exocrine Cell Clusters In Vitro. Open Virol J. 2013 Apr 5;7:49-56. doi: 10.2174/1874357901307010049. Print 2013.

Salvatoni A, Baj A, Bianchi G, Federico G, Colombo M, Toniolo A. (2013). Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes. Pediatr Diabetes, Epub ahead of print.

Herold KC, Vignali DA, Cooke A, Bluestone JA. (2013). Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol., 13(4):243-56.

Coppieters KT, von Herrath M. (2013). Antibody cross-reactivity and the viral aetiology of type 1 diabetes. J Pathol., 230(1):1-3.

Taylor-Fishwick DA, Weaver JR, Grzesik W, Chakrabarti S, Green-Mitchell S, Imai Y, Kuhn N, Nadler JL. (2013). Production and function of IL-12 in islets and beta cells. Diabetologia., 56(1):126-35.

Craig ME, Nair S, Stein H, Rawlinson WD. (2013). Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes., 14(3):149-58.

Ahmed ST, Akirav E, Bradshaw E, Buckner J, McKinney E, Quintana FJ, Waldron-Lynch F, Nepom J. (2013). Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes. Clin Exp Immunol., 172(2):178-85.

Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. (2013). Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors. Diabetes, Mar 22. Epub ahead of print.

Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi E, Sebastiani G, Masini M, Maugeri N, Porretti L, Bonfanti R, Meschi F, De Pellegrin M, Lesma A, Rossini S, Piemonti L, Marchetti P, Dotta F, Bosi E, Battaglia M. (2013). Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes. Jun;62(6):2072-7. doi: 10.2337/db12-1345. Epub 2013 Jan 24.

back to top

Abstracts & Oral Presentations

Pugliese, A. (2013). Islet Pathophysiology and Potential Targets for Therapy: Lessons from the JDRF nPOD. Second Annual Manning Diabetes Symposium, University of Virginia.

Richardson, S.J., Bone, A.J., Foulis, A.K., Morgan, N.G. (2013). VP1 expression in insulin-containing islets is associated with hyperexpression of Class I MHC in Type 1 diabetes. Diabetic Medicine, 30 (Suppl. 1):82.

back to top

Comments are closed.